MUSCAT: An innovative cancer research project by Omani scientist Al Qaidiyah has secured first place in a national competition, earning her the honor of representing Oman at the Falling Walls International Forum in Berlin this November, according to the Oman Observer.
Her groundbreaking work employs genetically engineered bacteria as a smart therapeutic tool to directly target tumor environments. These programmed bacteria can either release anti-cancer compounds or stimulate the immune system to attack tumors from within.
Unlike chemotherapy and radiation, this approach aims to minimize harmful side effects, offering a safer, more personalized treatment option. By selectively attacking tumor cells while sparing healthy tissues, the method could prove especially effective for advanced-stage cancers resistant to conventional therapies.
“What distinguishes this project is its reliance on smart microorganisms as a treatment tool, unlike most research that focuses on chemotherapy or radiation,” Al Qaidiyah explained.
Looking forward, she envisions developing a bacterial-based prototype for clinical trials, collaborating with international research institutions to validate the treatment, and eventually patenting the innovation as a global contribution from Oman to the fight against cancer.
